The <i>Mycobacterium smegmatis bd</i>-II terminal oxidase employs a carboxylate shift mechanism.

Kovalova, Terezia; Janczak, Mateusz; Gamiz-Hernandez, Ana P; Lundin, Daniel; Sharma, Soni; Vilhjálmsdóttir, Johanna; Sjöstrand, Dan; Kaila, Ville R I et al. · Proc Natl Acad Sci U S A · 2026

basic_science · Level V

Where this comes from

Abstract

Cytochrome <i>bd</i> is a terminal oxidase expressed under low oxygen conditions and central for the survival of many pathogens. Here, we characterize the cyt <i>bd</i>-II from <i><i>Mycobacterium</i> smegmatis</i>, a member of a hitherto uncharacterized evolutionary group (qOR-2) of <i>bd</i> oxidases, by combining biochemical studies with cryo-electron microscopy (cryo-EM), and multiscale simulations. Overexpressing the <i>appCB</i> operon in its native host led to production of a highly active <i>bd</i>-II (<i>k</i><sub>obs</sub> = 30 e<sup>-</sup> s<sup>-1</sup>) that together with a high-resolution (2.8 Å) cryo-EM structure and multiscale simulations reveal unique proton pathways and oxygen channels responsible for its function. We propose that a pH-dependent molecular switch, involving coordination changes of heme <i>d</i> and surrounding bulky residues regulate substrate access into the active site. Taken together, our findings provide detailed mechanistic insight of qOR-2 type <i>bd</i> oxidases, and a basis for understanding the evolution of the superfamily.

Medical subject headings